Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

B cell

Biopharmaceuticals in Plants Toward the Next Century of Medicine [Pg.150]

Macrophage m0 Derived from monocytes, these highly phagocytic cells engulf and digest pathogens [Pg.150]

Natural killer T cell NKTcell Subset of T cells, upon activation rapidly release large quantities of cytokines [Pg.150]

Cytokine None Cellular-signaling molecules, glycoproteins that are secreted by various immune cells [Pg.150]

Chemokine None Small proteins, subset of cytokines [Pg.150]

Keywords Antibodies B cells Effector memory T cells Follicular dendritic cells (FDCs) Immune privileged Regulatory T cells Stat4 Stat6 T-Bet [Pg.136]

As of today, the conhol of immune reactions in the brain attributed mostly to the specific cell membrane-bound molecules, soluble factors and brain-associated immune deviation (BRAID) reviewed by (Niederkom, 2006). [Pg.136]


Antibodies secreted by B cells bind to foreign material (antigen) and serve as tags or identifiers for such material. Antibody-tagged bacteria. [Pg.299]

An electrodialysis cell has the following dimensions (110 cm X 60 cm x 0.04 cm (thickness), and is used to treat water with a throughput velocity of 10 cm/sec. The product concentration is 0.0092 eq/Liter. The cell current efficiency is 0.892. Resistance across the cell is 0.205 ohm. The influent concentration is 125 mg/Liter of NaCl. Calculate the following (a) cell current, (b) cell power output, (c) the cell voltage, and (d) the energy consumption per equivalent of product transferred. [Pg.370]

In addition to antibodies, the immune system also consists of bone-marrow derived lymphocytes, or B cells, and T cells that come from the thymus gland, both of which (indirectly) produce antibodies. These cells, in turn, may be helped by helper cells (= H) and suppressed by suppressor cells (= S). Helper cells may be alarmed as to the presence of antigens by macrophages (= M) that eat the antigens and leave parts of their meal on their cell surface. [Pg.426]

The normal immune response is modeled using antibodies A, B cells, helpers H, suppressors S and antigens, or viruses, V. Each of these concentrations can be either high (= 1) or low 0). The dynamics is defined as follows ... [Pg.426]

We can interpret these equations in the following way. The first line assures us that antibodies will be present only when B cells, helper cells and antigens are all present. The second line states that B cells will grow if antigens and/or B cells are present and if helped by helper cells. The third line indicates that helper cells arise either if other helper cells ai e present or, if no suppressor cells are present, if there are any antigens. The fourth line yields suppressor cells if suppressor cells are already present and/or there are any helper cells. The last line implies that the antigen remains if there are no antibodies or vani.shes if antibodies are present. Since concentrations cannot exceed 1, it is understood that, in the above equations, 1 + 1 = 1. [Pg.427]

Nagasaw, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H., and Kishimoto T. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382 635-638. [Pg.145]

AIDS (acquired immunodeficiency syndrome) is the final stage of disease caused by infection with HIV. In this stage, the vims infection has severely affected the immune system, causing a depletion of CD4+ T-helper cells. AIDS is characterized by the manifestation of typical diseases caused by opportunistic infections (Pneumocystis carinii pneumonia, CMV retinitis, candidiasis of the esophagus, cerebral toxoplasmosis), neurological manifestations, cachexia, or certain tumors (Kaposi sarcoma of the skin, B-cell lymphoma). [Pg.51]

The limited efficacy of classical anticancer diugs can be explained in part by the compartment model of dividing (growth fraction, compartment A) and nondividing (compartment B) cells. The majority of antineoplastic diugs acts upon cycling cells and will hit, therefore, compartment A only. [Pg.154]

Recombinant humanized monoclonal antibodies have been used recently to target antigens that are preferentially located on cancer cells. Examples include trastuzumab and rituximab which are used to treat HER2 positive breast cancer and B-cell type lymphomas, respectively. Unwanted side effects include anaphylactic reactions. [Pg.156]

Bcl-2 (B-cell lymphoma-related gene) is major mammalian gene that is known to inhibit apoptosis. [Pg.250]

A second population of Th-cells, Th-2, regulates B-cell responses (see below) by secreting a different set of cytokines including IL-4, IL-5, IL-6, IL-10, or IL-13. [Pg.614]

A cytokine, secreted by TH2-cells, stimulates B-cells in different stages of their development. It may act as a growth factor or as a differentiation factor, causing B-lymphocytes to switch antibody to IgE. In T-cells it causes differentiation into TH2-cells. [Pg.647]

A cytokine, secreted by TH2-cells and mast cells, stimulates B-cell growth, acts as hematopoietic factor for growth factor eosinophils, and extends the life span of eosinophils. [Pg.647]


See other pages where B cell is mentioned: [Pg.299]    [Pg.299]    [Pg.299]    [Pg.300]    [Pg.302]    [Pg.302]    [Pg.303]    [Pg.303]    [Pg.315]    [Pg.310]    [Pg.310]    [Pg.505]    [Pg.506]    [Pg.428]    [Pg.15]    [Pg.59]    [Pg.107]    [Pg.134]    [Pg.150]    [Pg.266]    [Pg.267]    [Pg.284]    [Pg.288]    [Pg.435]    [Pg.538]    [Pg.603]    [Pg.603]    [Pg.604]    [Pg.614]    [Pg.615]    [Pg.615]    [Pg.625]    [Pg.630]    [Pg.631]    [Pg.643]    [Pg.715]    [Pg.789]   
See also in sourсe #XX -- [ Pg.299 ]

See also in sourсe #XX -- [ Pg.285 , Pg.296 ]

See also in sourсe #XX -- [ Pg.149 , Pg.150 ]

See also in sourсe #XX -- [ Pg.83 , Pg.831 ]

See also in sourсe #XX -- [ Pg.83 , Pg.95 , Pg.96 , Pg.97 , Pg.98 , Pg.182 , Pg.201 ]

See also in sourсe #XX -- [ Pg.592 , Pg.592 ]

See also in sourсe #XX -- [ Pg.386 , Pg.390 ]

See also in sourсe #XX -- [ Pg.500 , Pg.501 , Pg.521 ]

See also in sourсe #XX -- [ Pg.323 ]

See also in sourсe #XX -- [ Pg.214 ]

See also in sourсe #XX -- [ Pg.140 ]

See also in sourсe #XX -- [ Pg.140 ]

See also in sourсe #XX -- [ Pg.10 ]

See also in sourсe #XX -- [ Pg.212 , Pg.213 ]

See also in sourсe #XX -- [ Pg.128 ]

See also in sourсe #XX -- [ Pg.258 ]

See also in sourсe #XX -- [ Pg.576 ]

See also in sourсe #XX -- [ Pg.521 ]

See also in sourсe #XX -- [ Pg.204 ]

See also in sourсe #XX -- [ Pg.2 , Pg.3 , Pg.39 , Pg.41 , Pg.43 , Pg.60 , Pg.65 , Pg.123 , Pg.136 , Pg.142 , Pg.153 , Pg.158 , Pg.169 , Pg.187 , Pg.197 , Pg.220 ]

See also in sourсe #XX -- [ Pg.359 , Pg.492 , Pg.493 , Pg.494 ]

See also in sourсe #XX -- [ Pg.415 , Pg.416 , Pg.420 ]

See also in sourсe #XX -- [ Pg.352 , Pg.600 , Pg.614 ]

See also in sourсe #XX -- [ Pg.302 ]

See also in sourсe #XX -- [ Pg.22 , Pg.46 , Pg.65 , Pg.98 , Pg.115 ]

See also in sourсe #XX -- [ Pg.51 , Pg.74 , Pg.97 , Pg.112 , Pg.120 , Pg.168 , Pg.190 , Pg.242 , Pg.254 , Pg.301 ]

See also in sourсe #XX -- [ Pg.67 ]

See also in sourсe #XX -- [ Pg.79 , Pg.80 , Pg.81 , Pg.82 , Pg.83 , Pg.84 ]

See also in sourсe #XX -- [ Pg.158 , Pg.160 , Pg.161 , Pg.168 ]

See also in sourсe #XX -- [ Pg.25 , Pg.26 , Pg.30 , Pg.31 , Pg.32 , Pg.35 , Pg.37 , Pg.42 , Pg.43 , Pg.51 , Pg.52 ]

See also in sourсe #XX -- [ Pg.414 , Pg.420 ]

See also in sourсe #XX -- [ Pg.23 , Pg.74 , Pg.107 , Pg.118 ]




SEARCH



Anti-B-cell lymphoma

Antibodies by B-cells

Antibody diversity and B cell subsets

Autoreactive B-cells

Avian B cells

B Cell Responses in MS

B Electrochemical Cells

B cell activating factor

B cell clones

B cell epitopes

B cell follicular

B cell lymphoma protein

B cell lymphoma-2 (Bcl

B cell lymphopoiesis

B cell proliferation

B cell receptors

B cell stimulating factor

B cell tolerance

B cells activated

B cells activation

B cells defects

B cells developing

B cells differentiation

B cells effector

B cells in rheumatoid arthritis

B cells progenitors

B cells, cancerous

B cells, development

B precursor cell

B-Cell Neoplasia

B-Cell Response

B-Class F-Cell

B-cell antigen receptor

B-cell chronic lymphocytic leukemia

B-cell clonal selection and proliferation

B-cell determinants

B-cell function

B-cell growth factor

B-cell leukaemia

B-cell leukemia

B-cell line

B-cell lymphomas

B-cell lysis

B-cell migration

B-cell neoplasms

B-cell numbers

B-cell prolymphocytic leukemia

B-cell receptor signaling

B-cell receptor signaling materials required

B-cell regeneration

B-cell specific activator protein

B-cell targeted therapies

B-cell trafficking

B-cell transcription factors

B-cell tumor

B-cells polyclonal activation

Brain and B Cells

B„ cell bioassay

Diffuse large B-cell lymphoma

EBV transformation of B cells

Extranodal marginal zone B-cell lymphoma

Gastric B-cell lymphoma

Hodgkin’s lymphoma B-cells

Human B Cell Line

Human B-cells

Immortalization of B cells

Immune response B cells

Immune system B cells

Lymphocytes B cells

Marginal zone B-cell lymphoma

Marginal zone B-cell lymphoma of MALT

Mature B cell neoplasms

Memory B and T cells

Memory B cells

Naive B-cells

Neoplastic B cells

Nodal marginal zone B-cell lymphoma

Non-Hodgkin’s lymphoma B-cell

Nuclear factor kappa-light-chain-enhancer of activated B cells

Patterns of immunoglobulin gene expression during B cell ontogeny

Polyclonal B-cell proliferation

Polyclonal activation of B-cells

Pre-B cells

Pre-B-cell colony-enhancing factor

Pre-B-cell growth stimulating factor

Primary mediastinal large B-cell lymphoma

Regulate B-Cells in the Intestine

Small B-cell lymphoma

T and B cell Antigen Receptors

T and B cell, interaction

T and B cells

T- B-cell interaction

Targeting B-cells in inflammatory disease

Type B cells

© 2024 chempedia.info